Skip to main navigation Skip to search Skip to main content

Getting to know ovarian cancer: Focusing on the effect of LncRNAs in this cancer and the effective signaling pathways

  • Abdullah Ali Alzahrani
  • , Yasir Qasim Almajidi
  • , Saade Abdalkareem Jasim
  • , Ahmed Hjazi
  • , Bokov Dmitry Olegovich
  • , Adnan Taan Alkhafaji
  • , Hussam Abdali Abdulridui
  • , Batool Ali Ahmed
  • , Ahmed Alawadi
  • , Ali Alsalamy

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

This article undertakes a comprehensive investigation of ovarian cancer, examining the complex nature of this challenging disease. The main focus is on understanding the role of long non-coding RNAs (lncRNAs) in the context of ovarian cancer (OC), and their regulatory functions in disease progression. Through extensive research, the article identifies specific lncRNAs that play significant roles in the intricate molecular processes of OC. Furthermore, the study examines the signaling pathways involved in the development of OC, providing a detailed comprehension of the underlying molecular mechanisms. By connecting lncRNA dynamics with signaling pathways, this exploration not only advances our understanding of ovarian cancer but also reveals potential targets for therapeutic interventions. The findings open up opportunities for targeted treatments, highlighting the importance of personalized approaches in addressing this complex disease and driving progress in ovarian cancer research and treatment strategies.

Original languageEnglish
Article number155084
JournalPathology Research and Practice
Volume254
DOIs
StatePublished - Feb 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • LncRNA- HOTAIR
  • LncRNAs
  • Ovarian cancers
  • Signaling pathways

Fingerprint

Dive into the research topics of 'Getting to know ovarian cancer: Focusing on the effect of LncRNAs in this cancer and the effective signaling pathways'. Together they form a unique fingerprint.

Cite this